This inventor holds 14 USPTO granted patents and 1 EPO patent. Top assignees: Lipha, Lyonnaise Industrielle Pharmaceutique, Merck Patent Gesellschaft MIT Beschrankter Haftung, Lipha. Active years: 1977-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Lyon, FR (1977 - 1978)
- Decines Charpieu, FR (1986 - 1988)
- Bonhomme, FR (1992)
- Lyons, FR (1978 - 2009)
Company Filing History:
9 out of 34 
2 out of 1,248 
1 out of 5 
Years Active: 1977-2009
Title: The Innovations of Jean-Jacques Berthelon
Introduction
Jean-Jacques Berthelon is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. With a total of 14 patents to his name, Berthelon's work has had a considerable impact on medical treatments.
Latest Patents
Among his latest patents are innovations related to butyric acid derivatives. The present invention pertains to a compound of a specific formula, which is useful in the treatment of dyslipidaemia, atherosclerosis, and diabetes. Another significant patent involves dihydrobenzodiazepins, which are benzodiazepine derivatives that can be used for treating dyslipidemia, atherosclerosis, diabetes, and its complications. These advancements highlight Berthelon's commitment to improving health outcomes through innovative solutions.
Career Highlights
Throughout his career, Jean-Jacques Berthelon has worked with several prominent companies in the pharmaceutical industry. Notable organizations include Lipha, Lyonnaise Industrielle Pharmaceutique, and Merck Patent Gesellschaft mit beschränkter Haftung. His experience in these companies has allowed him to develop and refine his inventions, contributing to advancements in medical science.
Collaborations
Berthelon has collaborated with several professionals in his field, including Philippe Briet and Jean-Jacques Zeiller. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his inventions.
Conclusion
Jean-Jacques Berthelon is a distinguished inventor whose work has significantly influenced the pharmaceutical industry. His innovative patents and collaborations demonstrate his dedication to advancing medical treatments. Through his contributions, Berthelon continues to make a lasting impact on health and wellness.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile